/stocks — the workspaceLOADING
All BIOT SEC filings, by type → · Earnings date & implied move · Search inside filings
BIOT is not among the 142 companies we ingest every day, so it is not in the fundamentals screener or the size and group lists built from it. This page reads its SEC filings when the page is built. Ask us to add it: we keep a count per ticker and nothing about you.
INSTINCT BIO TECHNICAL CO HOLDINGS INC. (BIOT) is a perfumes, cosmetics & other toilet preparations company. Fundamentals from SEC filings; prices are end-of-day.
Every filed figure on this page is free to read, dated and sourced; no column is held back for a paid plan. Each section with figures says what date they are true as of and where they come from.
No chart read for BIOT: needs 84 sessions on file; 76 are.
What’s behind BIOT’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
No recent 10-K / 10-Q / 8-K filings found.
Has BIOT been issuing shares? Offering history →
Volume against its own history: 3% of its last 75 sessions were lighter than the last one, the 2026-11-09 session. End-of-day bars (Databento). Volume detail
A plain-English read on BIOT plus an auto-SWOT, built from BIOT's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts, a bull, a bear, a risk manager, and a PM, debate BIOT using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Ask about BIOT’s revenue, earnings, valuation, filings, insiders or Congress trades. Answers come only from the numbered evidence the research brief uses, each citing the items it rests on. A question about one figure is answered by code, free. One that puts figures together is 1 generation (Pro). A question about whether to buy, sell or hold, how much, or where the price goes gets a refusal.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Closes only, split-adjusted. Range of the 76 sessions on file, under a full year. An average needs that many sessions on file to print. These are measurements, not support, resistance or targets. Chart with studies
Projected from BIOT's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentBIOT files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
Nothing on file for BIOT from Nov 10, 2026 to Nov 23, 2026 in these sources: earnings date and filing deadline.
| Event | Result |
|---|---|
| Earnings date | nothing in the window. No date in the window: no regular report cadence in the filings. |
| Filing deadline | nothing in the window. Nothing in the window: the 20-F for the fiscal year ending between Jul 15, 2027 and Jul 29, 2027, due four months after it, falls due between Nov 15, 2027 and Nov 29, 2027, after it. Newest periodic report on file: the 20-F for the period ending Jul 23, 2026, filed Jul 29, 2026. filing list on EDGAR |
| Ex-dividend date | not covered. Not checked. This attestation does not cover ex-dividend dates. |
This records what these sources returned when they were read. It is not a forecast: a company can announce an event at any time, and ex-dividend dates are not covered. Window 2026-11-10 to 2026-11-23, Eastern dates. Deadlines follow SEC Rules 13a-1 and 13a-13 and Form 20-F, moved past weekends and federal holidays by Rule 0-3.
1 of the 1 checks that ran found nothing new for BIOT. 3 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
No fair value band on this page build. No annual filing figures reached the estimators, either because the SEC read did not finish or because BIOT has not filed annual figures yet. That is a statement about the read, not about BIOT’s value. The page rebuilds daily.
Every refusal recorded for BIOT → · How often we decline, and why →
Group: Perfumes, Cosmetics & Other Toilet Preparations, the SEC industry code BIOT files under. 3 companies in our stored table file under it.
| Metric | BIOT | Group median | 25th to 75th percentile | Where BIOT sits |
|---|---|---|---|---|
| Net marginnet income divided by revenue, same fiscal year | Withheld: 3 companies in this SIC group have the figure on file, and a group prints from 6. | |||
| Free cash flow marginoperating cash flow less capital expenditure, divided by revenue, same fiscal year | Withheld: 3 companies in this SIC group have the figure on file, and a group prints from 6. | |||
| Return on equitynet income divided by stockholders’ equity at the fiscal year end | Withheld: 3 companies in this SIC group have the figure on file, and a group prints from 6. | |||
One filed metric per row, each a ratio of two figures from the same annual report; no composite and no grade. Percentile is the share of the group’s other companies with a lower figure. A group prints from 6 companies with the figure. The group is drawn from our stored table (the S&P 500 issuers and the companies we cover, each with its newest annual report read), not from every filer in the class. Industry pages show the same medians by group.
The latest periodic report’s cover carries no incorporation tag, so this comes from EDGAR’s company directory instead. That is a separate administrative record rather than the company’s own statement, and it does not always match the filings where both exist.
Latest periodic report checked: 20-F filed 2026-07-29. Filings checked 2026-11-10. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
No tracked institution reported a position in BIOT in the latest 13F round.
No open-market Form 4 buys or sells reported for BIOT in the last ~6 months.
No lawmaker has disclosed a trade in BIOT under the STOCK Act.